MedPath

Efficacy and safety of low-dose steroid treatment in asymptomatic patients with autoimmune pancreatitis.

Not Applicable
Conditions
autoimmune pancreatitis
Registration Number
JPRN-UMIN000022633
Lead Sponsor
Osaka University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who have already administered steroid and/or immunosuppressive drugs 2) Severe drug hypersensitivity 3) Active infection 4) Infection of HBV (patients with HBc antigen-positive or with HBs antibody-positive, or patients previously unvaccinated against HBV with HBs antibody-positive alone) 5) Patients who require the treatment of cerebrovascular or cardiovascular disorder 6) Patients with uncontrollable diabetes mellitus 7) Patients with uncontrollable hypertension 8) Patients with severe mental disorder 9) Patients with severe cataract or glaucoma 10) Patients with severe renal disorder 11) Patients with severe lung disorder 12) Patients with severe liver disorder 13) Patients with severe osteoporosis 14) Past history of pancreatectomy 15) Pregnant or lactating women, or women with suspected pregnancy 16) Patients seems inadequate for this study judged by investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The sequential change of pancreatic exocrine function
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath